Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...

Substance Use Disorders Affecting Sleep

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Insufficient Sleep and Sleep Deprivation

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Variability in the effects of ketamine enantiomers across animal models of depression and implications for human studies.

British journal of pharmacology·2026

Same author

Clinical, Volumetric and Microcirculatory Outcomes of Multiple Gingival Recession Treatment with a Porcine Acellular Dermal Matrix: A Case Series.

The International journal of periodontics & restorative dentistry·2026

Same author

Differential effects of ketamine enantiomers on EEG parameters including the gamma-delta shift phenomenon.

British journal of pharmacology·2026

Same author

Complex Regulation of RETINOBLASTOMA-RELATED's Interactions With E2Fs via Phosphorylation.

Plant, cell & environment·2026

Same author

Levels of aggregation of proteins related to mental illness, assayed by insolubility, vary across the brains of individuals.

Scientific reports·2026

Same author

The evolution of gene regulation in mammalian cerebellum development.

Science (New York, N.Y.)·2026

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a

Eszter Kirilly¹, Eszter Molnar, Brigitta Balogh

¹Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary.

The International Journal of Neuropsychopharmacology

|February 12, 2008

Summary

This summary is machine-generated.

Ecstasy (MDMA) damages brain serotonin transporter (5-HTT) levels and alters sleep patterns in rats. While most brain regions recover within 180 days, the hippocampus shows lasting changes, impacting sleep architecture.

More Related Videos

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Related Experiment Videos

Last Updated: Jul 7, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Area of Science:

Neuroscience
Pharmacology
Sleep Science

Background:

Recreational drug ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is known to affect brain serotonin neurons.
Previous studies suggest MDMA-induced neurotoxicity, but detailed analyses of damage and recovery, alongside functional sleep measures, are lacking.

Purpose of the Study:

To investigate the long-term effects of a single MDMA dose on serotonergic markers and sleep patterns in rats.
To analyze the recovery of the serotonergic system and sleep architecture following MDMA exposure.

Main Methods:

Male Dark Agouti rats received a single dose of MDMA (15 mg/kg).
Serotonergic markers (5-HTT density, 5-HTT mRNA) and sleep patterns (EEG polygraphy) were assessed at 7, 21, and 180 days post-treatment.
Morphometric and functional analyses were performed.

Main Results:

MDMA caused significant, widespread reductions in 5-HTT density in the cortex, hippocampus, hypothalamus, and brainstem at 7 and 21 days.
Transient changes in 5-HTT mRNA expression were observed in raphe nuclei.
Sleep alterations included reduced REM sleep latency, increased delta power during non-REM sleep, and increased sleep fragmentation.
Recovery of 5-HTT density and sleep patterns was observed by 180 days, except in the hippocampus.

Conclusions:

MDMA induces transient, long-term changes in the serotonergic system and sleep patterns, with the hippocampus showing persistent alterations.
The observed sleep disturbances (reduced REM latency, increased fragmentation) resemble those seen in depression.
This study provides detailed insights into MDMA's neurotoxic effects and subsequent recovery on brain function and sleep.